期刊
JOURNAL OF MEDICINAL CHEMISTRY
卷 48, 期 3, 页码 658-660出版社
AMER CHEMICAL SOC
DOI: 10.1021/jm0496279
关键词
-
资金
- NIGMS NIH HHS [R01 GM044853] Funding Source: Medline
Human cytidine deaminase (CDA) is an enzyme prominent for its role in catalyzing metabolic processing of nucleoside-type anticancer and antiviral agents. It is thus a promising target for the development of small molecule therapeutic adjuvants. We report the first crystal structure of human CDA as a complex with a tight-binding inhibitor, diazepinone riboside 1. The structure reveals that inhibitor 1 is able to establish a canonical pi/pi-interaction with a key active site residue, Phe 137.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据